BORTEZOMIB (VELCADE)-MELPHALAN-PREDNISONE (VMP) VERSUS VELCADE-THALIDOMIDE-PREDNISONE (VTP) IN ELDERLY UNTREATED MULTIPLE MYELOMA (MM) PATIENTS

被引：0
|
作者：
Mateos, M. V. [1 ]
Oriol, A. [2 ]
Martinez, J. [3 ]
Cibeira, M. T. [4 ]
de Paz, R. [5 ]
Terol, M. J. [6 ]
Garcia-Larana, J. [7 ]
Bengoechea, E. [8 ]
Martinez, R. [9 ]
Martin, A. [10 ]
de Arriba, F. [11 ]
Palomera, L. [12 ]
Hernandez, J. M. [13 ]
Bello, J. L. [14 ]
Martin, M. L. [15 ]
Gonzalez, Y. [16 ]
Lahuerta, J. J. [3 ]
Blade, J. [4 ]
San Miguel, J. [1 ]
机构：
[1] Univ Hosp Salamanca, Salamanca, Spain
[2] Hosp Badalona Germans Trias & Pujol, Badalona, Spain
[3] Hosp 12 Octubre, E-28041 Madrid, Spain
[4] Hosp Clin Barcelona, Barcelona, Spain
[5] Hosp La Paz, Madrid, Spain
[6] Hosp Clin, Valencia, Spain
[7] Hosp Ramon & Cajal, E-28034 Madrid, Spain
[8] Hosp Donostia, San Sebastian, Spain
[9] Hosp Clin Madrid, Madrid, Spain
[10] Hosp Virgen Concha, Zamora, Spain
[11] Hosp Morales Messeguer, Murcia, Spain
[12] Hosp Lozano Blesa, Zaragoza, Spain
[13] Hosp Gen Segovia, Segovia, Spain
[14] Univ Santiago, Complejo Hosp, Santiago De Compostela, Spain
[15] Hosp San Pedro Alcantara, Caceres, Spain
[16] Inst Oncol Josep Trueta, Girona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2009年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0471
引用
收藏
页码：190 / 190
页数：1
相关论文
共 50 条
  • [1] Bortezomib (Velcade)-Melphalan-Prednisone (VMP) Versus Velcade-Thalidomide-Prednisone (VTP) in Elderly Untreated Multiple Myeloma Patients: Which Is the Best Partner for Velcade: An Alkylating or An Immunomodulator Agent?
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez, Joaquin
    Cibeira, M. Teresa
    de Paz, Raquel
    Terol, M. Jose
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martinez, Rafael
    Martin, Alejandro
    de Arriba, Felipe
    Palomera, Luis
    Hernandez, Jose
    Bello, Jose-Luis
    Martin, Maria-Luisa
    Gonazlez, Yolanda
    Blade, Joan
    Jose Lahuerta, Juan
    San Miguel, J. F.
    BLOOD, 2008, 112 (11) : 243 - 243
  • [2] Bortezomib (Velcade)/Melphalan/Prednisone (VMP) Versus Velcade/Thalidomide/Prednisone (VTP) in Elderly
    Mateos, M. V.
    Martin, M. L.
    Gonzalez, Y.
    Lahuerta, J. J.
    Blade, J.
    Oriol, A.
    Martinez, J.
    Cibeira, M. T.
    de Paz, R.
    Terol, M. J.
    Garcia, J.
    Bengoechea, E.
    Martinez, R.
    Martin, A.
    de Arriba, F.
    Palomera, L.
    Hernandez, J. M.
    Bello, J. L.
    San Miguel, J.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S25 - S25
  • [3] FISH AND IMMUNOPHENOTYPE IN ELDERLY UNTREATED MULTIPLE MYELOMA PATIENTS ENTERED IN A PROSPECTIVE RANDOMIZED TRIAL OF VELCADE-MELPHALAN-PREDNISONE AND THALIDOMIDE VS VELCADE-MELPHALAN-PREDNISONE
    Caltagirone, S.
    Ruggeri, M.
    Gilestro, M.
    Aschero, S.
    Nozzoli, C.
    Ria, R.
    Rossi, D.
    Boccadoro, M.
    Palumbo, A.
    Omede, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 132 - 133
  • [4] A Prospective, Multicenter, Randomized, Trial of Bortezomib/Melphalan/Prednisone (VMP) Versus Bortezomib/Thalidomide/Prednisone (VTP) as Induction Therapy Followed by Maintenance Treatment with Bortezomib/Thalidomide (VT) Versus Bortezomib/Prednisone (VP) in Elderly Untreated Patients with Multiple Myeloma Older Than 65 Years
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez, Joaquin
    Teresa Cibeira, Ma
    Gutierrez, Norma C.
    Jose Terol, Maria
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin Garcia-Sancho, Alejandro
    Martinez, Rafael
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose
    Sureda, Anna
    Bello, Jose-Luis
    Jose Lahuerta, Juan
    Blade, Joan
    San-Miguel, Jesus F.
    BLOOD, 2009, 114 (22) : 3 - 4
  • [5] Bortezomib, melphalan, and prednisone versus bortezomib, thalidomide, and prednisone as induction therapy followed by maintenance treatment with bortezomib and thalidomide versus bortezomib and prednisone in elderly patients with untreated multiple myeloma: a randomised trial
    Mateos, Maria-Victoria
    Oriol, Albert
    Martinez-Lopez, Joaquin
    Gutierrez, Norma
    Teruel, Ana-Isabel
    de Paz, Raquel
    Garcia-Larana, Jose
    Bengoechea, Enrique
    Martin, Alejandro
    Diaz Mediavilla, Joaquin
    Palomera, Luis
    de Arriba, Felipe
    Gonzalez, Yolanda
    Hernandez, Jose-Mariano
    Sureda, Ana
    Bello, Jose-Luis
    Bargay, Joan
    Penalver, Francisco-Javier
    Ribera, Jose-Maria
    Martin-Mateos, Maria-Luisa
    Garcia-Sanz, Ramon
    Cibeira, Maria-Teresa
    Martin Ramos, Maria-Luisa
    Vidriales, Maria-Belen
    Paiva, Bruno
    Montalban, Maria-Angeles
    Lahuerta, Juan-Jose
    Blade, Joan
    San Miguel, Jesus-Fernando
    LANCET ONCOLOGY, 2010, 11 (10): : 934 - 941
  • [6] Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression
    Lopez, Aurelio
    Valero, Marta
    Lorenzo, Jose Ignacio
    Mateos, Maria-Victoria
    Oriol, Albert
    Joaquin, Martinez
    Perez, Montserrat
    Martinez, Rafael
    de Paz, Raquel
    Granell, Miguel
    De Arriba, Felipe
    Blanchard, M. Jesus
    Javier Penalver, Francisco
    Bello, Jose Luis
    Martin, Maria Luisa
    Bargay, Joan
    Blade, Joan
    Lahuerta, Juan Jose
    San Miguel, Jesus F.
    De La Rubia, Javier
    BLOOD, 2013, 122 (21)
  • [7] Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
    Zweegman, Sonja
    van der Holt, Bronno
    Mellqvist, Ulf-Henrik
    Salomo, Morten
    Bos, Gerard M. J.
    Levin, Mark-David
    Visser-Wisselaar, Heleen
    Hansson, Markus
    van der Velden, Annette W. G.
    Deenik, Wendy
    Gruber, Astrid
    Coenen, Juleon L. L. M.
    Plesner, Torben
    Klein, Saskia K.
    Tanis, Bea C.
    Szatkowski, Damian L.
    Brouwer, Rolf E.
    Westerman, Matthijs
    Leys, M. B. L.
    Sinnige, Harm A. M.
    Haukas, Einar
    van der Hem, Klaas G.
    Durian, Marc F.
    Mattijssen, E. J. M.
    van de Donk, Niels W. C. J.
    Stevens-Kroef, Marian J. P. L.
    Sonneveld, Pieter
    Waage, Anders
    BLOOD, 2016, 127 (09) : 1109 - 1116
  • [8] Prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) for newly diagnosed elderly myeloma
    Renaud, Loic
    Leleu, Xavier
    HEMATOLOGIE, 2014, 20 (03): : 138 - 138
  • [9] Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
    Morabito, Fortunato
    Bringhen, Sara
    Larocca, Alessandra
    Wijermans, Pierre
    Victoria Mateos, Maria
    Gimsing, Peter
    Mazzone, Carla
    Gottardi, Daniela
    Omede, Paola
    Zweegman, Sonja
    Jose Lahuerta, Juan
    Zambello, Renato
    Musto, Pellegrino
    Magarotto, Valeria
    Schaafsma, Martijn
    Oriol, Albert
    Juliusson, Gunnar
    Cerrato, Chiara
    Catalano, Lucio
    Gentile, Massimo
    Isabel Turel, Ana
    Liberati, Anna Marina
    Cavalli, Maide
    Rossi, Davide
    Passera, Roberto
    Rosso, Stefano
    Beksac, Meral
    Cavo, Michele
    Waage, Anders
    San Miguel, Jesus
    Boccadoro, Mario
    Sonneveld, Pieter
    Palumbo, Antonio
    Offidani, Massimo
    AMERICAN JOURNAL OF HEMATOLOGY, 2014, 89 (04) : 355 - 362
  • [10] SUPERIOR EFFICACY WITH BORTEZOMIB PLUS MELPHALAN-PREDNISONE (VMP) VERSUS MELPHALAN-PREDNISONE (MP) ALONE IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA (MM): RESULTS OF THE PHASE III MMY-3002 VISTA STUDY
    San-Miguel, J.
    Schlag, R.
    Khuageva, N.
    Dimopoulos, M.
    Shpilberg, O.
    Kropff, M.
    Spicka, I.
    Petrucci, M.
    Palumbo, A.
    Samoilova, O.
    Dmoszynska, A.
    Abdulkadyrov, K.
    Schots, R.
    Jiang, B.
    Mateos, M.
    Anderson, K.
    Esseltine, D.
    Liu, K.
    Cakana, A.
    Van de Velde, H.
    Richardson, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 192 - 193
12345